Table 2. The Status of Plasma Adiponectin Level in 1167 Sets and Subgroup.
Factors | Case | Control | P |
---|---|---|---|
mean ± SD | mean ± SD | ||
All patients | n = 1167 | n = 1167 | |
Total adiponectin (μg/ml) | 6.34(3.54) | 6.56(3.72) | 0.150 |
HMW adiponectin (μg/ml) | 2.52(1.88) | 2.58(1.88) | 0.403 |
HMW/total adiponectin ratio | 0.38(0.15) | 0.38(0.15) | 0.590 |
Postmenopausal women | n = 396 | n = 339 | |
Total adiponectin (μg/ml) | 6.58 (3.74) | 6.95 (4.08) | 0.201 |
HMW adiponectin (μg/ml) | 2.59 (2.01) | 2.84 (2.14) | 0.113 |
HMW/total adiponectin ratio | 0.37 (0.15) | 0.40 (0.15) | 0.016 |
Non-postmenopausal women | n = 745 | n = 785 | |
Total adiponectin (μg/ml) | 6.24 (3.46) | 6.44 (3.57) | 0.232 |
HMW adiponectin (μg/ml) | 2.49 (1.83) | 2.49 (1.76) | 0.410 |
HMW/total adiponectin ratio | 0.38 (0.16) | 0.38 (0.15) | 0.660 |
Positive family history of BC | n = 76 | n = 45 | |
Total adiponectin (μg/ml) | 6.37 (3.42) | 5.18 (2.74) | 0.049 |
HMW adiponectin (μg/ml) | 2.92 (1.95) | 2.18 (1.54) | 0.032 |
HMW/total adiponectin ratio | 0.44 (0.13) | 0.42 (0.16) | 0.480 |
Negative family history of BC | n = 1091 | n = 1122 | |
Total adiponectin (μg/ml) | 6.34 (3.55) | 6.62 (3.74) | 0.081 |
HMW aidponectin (μg/ml) | 2.49 (1.87) | 2.60 (1.89) | 0.832 |
HMW/total adiponectin ratio | 0.38 (0.16) | 0.38 (0.15) | 0.714 |
BMI<24.0 | n = 541 | n = 577 | |
Total adiponectin (μg/ml) | 6.85 (3.60) | 6.99 (3.87) | 0.091 |
HMW aidponectin (μg/ml) | 2.81 (1.95) | 2.81 (2.03) | 0.992 |
HMW/total adiponectin ratio | 0.39 (0.16) | 0.39 (0.16) | 0.974 |
BMI> = 24.0 | n = 576 | n = 550 | |
Total adiponectin (μg/ml) | 5.88 (3.39) | 6.13 (3.56) | 0.261 |
HMW aidponectin (μg/ml) | 2.23 (1.77) | 2.34 (1.68) | 0.738 |
HMW/total adiponectin ratio | 0.36 (0.15) | 0.37 (0.15) | 0.951 |
BC, breast cancer; BMI, body mass index; SD, standard deviation.